Therapeutic Advances in Endocrinology and Metabolism

Papers
(The TQCC of Therapeutic Advances in Endocrinology and Metabolism is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review124
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review114
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults60
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis39
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study33
Controversies in the management of active Charcot neuroarthropathy29
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach26
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity24
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers22
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses22
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease21
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system21
Update on genetics and epigenetics in metabolic associated fatty liver disease20
Effectiveness of open-source Android artificial pancreas systems for glucose management in patients with type 1 diabetes: a real-world study18
Is there a causal relationship between hypothyroidism and hyponatremia?17
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor17
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus17
Pheochromocytoma: a changing perspective and current concepts17
Diagnostic performance of morning basal serum cortisol for assessing adrenal reserve: a single-center experience from the United Arab Emirates16
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study16
Risk factor management over two decades in hospitalised patients with chronic limb-threatening ischaemia with and without diabetes mellitus15
Retraction notice15
A study looking at how missed somatropin injections affect growth in children with growth hormone deficiency: a plain language summary of publication15
Management strategies for patients with insulin allergy at risk of acute complications: experience from a case report15
The legacy effect of early HbA1c control on microvascular complications and hospital admissions in type 2 diabetes: findings from a large UK study15
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective15
Limitation of the current Lin-Weiss-Bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed by the Lin-Weiss-Bis14
Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study13
Potential of duodenal mucosal resurfacing in achieving glycemic control in Asians with type 2 diabetes13
The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis13
Gender-affirming endocrine care for youth with a nonbinary gender identity13
Temporal patterns of inpatient hypoglycaemia are treatment-dependent12
Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes12
Bone health in transgender people: a narrative review12
The missing piece in post-transplant bone health: tertiary hyperparathyroidism management12
Analysis of vitamin D nutritional status and disease risk factors in patients with subacute thyroiditis11
Implications of gender-affirming endocrine care for sports participation11
Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled c11
Exploring the weight bias of professionals working in the field of obesity with a mobile IAT: a pilot study11
Thanks to Reviewers11
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions10
0.046324968338013